News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
260,454 Results
Type
Article (13557)
Company Profile (110)
Press Release (246787)
Section
Business (87931)
Career Advice (461)
Deals (15323)
Drug Delivery (63)
Drug Development (36521)
Employer Resources (49)
FDA (6259)
Job Trends (6182)
News (150003)
Policy (14005)
Tag
Academia (435)
Alliances (23071)
Alzheimer's disease (346)
Approvals (6248)
Artificial intelligence (55)
Bankruptcy (143)
Best Places to Work (4296)
Biosimilars (37)
Biotechnology (44)
Breast cancer (37)
Cancer (273)
Career advice (404)
Cell therapy (37)
Clinical research (30296)
Collaboration (123)
Compensation (55)
COVID-19 (746)
C-suite (39)
Data (267)
Diabetes (45)
Diagnostics (1228)
Drug pricing (56)
Earnings (31312)
Employer resources (43)
Events (36570)
Executive appointments (138)
FDA (6416)
Funding (86)
Gene therapy (57)
GLP-1 (284)
Government (1262)
Healthcare (3516)
Infectious disease (762)
Inflammatory bowel disease (45)
Interviews (58)
IPO (5803)
Job creations (2048)
Job search strategy (372)
Layoffs (166)
Legal (3407)
Lung cancer (42)
Manufacturing (81)
Medical device (1259)
Medtech (1261)
Mergers & acquisitions (9525)
Metabolic disorders (147)
Neuroscience (434)
NextGen Class of 2024 (1580)
Non-profit (589)
Northern California (365)
Obesity (92)
Opinion (108)
Patents (50)
People (28381)
Pharmaceutical (64)
Phase I (7877)
Phase II (12809)
Phase III (11515)
Pipeline (90)
Podcasts (38)
Policy (43)
Postmarket research (1399)
Preclinical (3156)
Radiopharmaceuticals (116)
Rare diseases (75)
Real estate (2629)
Regulatory (9794)
Research institute (562)
Resumes & cover letters (55)
Southern California (371)
Startups (1624)
United States (3666)
Vaccines (107)
Weight loss (74)
Date
Today (33)
Last 7 days (246)
Last 30 days (919)
Last 365 days (12758)
2024 (10798)
2023 (14244)
2022 (19556)
2021 (20068)
2020 (19033)
2019 (14886)
2018 (11713)
2017 (13889)
2016 (13129)
2015 (15474)
2014 (12424)
2013 (10593)
2012 (11401)
2011 (11923)
2010 (10888)
Location
Africa (312)
Arizona (38)
Asia (19739)
Australia (2550)
California (845)
Canada (546)
China (95)
Connecticut (36)
Europe (38661)
Florida (119)
Illinois (95)
Indiana (78)
Kansas (50)
Maryland (136)
Massachusetts (742)
Minnesota (47)
New Jersey (361)
New York (241)
North Carolina (263)
Northern California (365)
Ohio (35)
Pennsylvania (249)
South America (498)
Southern California (371)
Texas (111)
Washington State (63)
260,454 Results for "maruishi pharmaceutical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Allay Therapeutics Announces Development and Commercialization Agreement with Maruishi Pharmaceutical for Ultra-Sustained Pain Therapeutics in Japan
Allay Therapeutics, Inc. (Allay) today announced that they have entered into a license agreement with Maruishi Pharmaceutical Co., Ltd. (Maruishi), providing Maruishi with exclusive rights to develop and commercialize Allay’s lead investigational drug candidate, ATX101, and other ultra-sustained analgesic implantable drug candidates for acute pain in Japan.
December 18, 2023
·
4 min read
Business
Cara Therapeutics Announces Approval of KORSUVA® IV Injection Syringe in Japan for the Treatment of Pruritus in Hemodialysis PatientsApproval triggers $1.5 million milestone payment to Cara
Cara Therapeutics, Inc. today announced that its licensing partner Maruishi Pharmaceutical Co., Ltd. received manufacturing and marketing approval from Japan’s Ministry of Health, Labour and Welfare for KORSUVA ® IV Injection Syringe for the treatment of pruritus in hemodialysis patients.
September 25, 2023
·
4 min read
Biotech Beach
ChromaDex to Launch Niagen+, the First-Of-Its-Kind Pharmaceutical-Grade Intravenous and Injectable Niagen® (Patented Nicotinamide Riboside Chloride or NRC)
ChromaDex Corp., the global authority on nicotinamide adenine dinucleotide research and its application to healthy aging, unveils Niagen+, the first-of-its-kind pharmaceutical-grade Niagen®.
June 13, 2024
·
9 min read
Business
Fennec Pharmaceuticals Announces Management Change
Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced that Adrian Haigh has departed from his position as Fennec’s Chief Operating Officer as of June 30, 2024.
July 1, 2024
·
4 min read
Provectus Biopharmaceuticals Announces Acceptance of Pharmaceutical-Grade Rose Bengal Sodium Abstract for Poster Presentation at 2024 Society for Investigative Dermatology (SID) Annual Meeting
Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that data from ongoing preclinical research on the topical administration of a formulation of Provectus’s proprietary, pharmaceutical-grade, small molecule, rose bengal sodium (“RBS”) drug substance are being presented at the annual meeting of the Society for Investigative Dermatology (“SID”), to be held May 15-18, 2024 in Dallas, Texas.
February 29, 2024
·
3 min read
Deals
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Deciphera Pharmaceuticals, Inc. today announced that it has entered into a definitive merger agreement with ONO Pharmaceutical Co., Ltd.
April 29, 2024
·
10 min read
Press Releases
Bora Pharmaceuticals to Expand Rare Disease Portfolio with Acquisition of US-Based Pyros Pharmaceuticals
October 28, 2024
·
9 min read
BioMidwest
Aurorium Launches Haelium™ Pharmaceutical Solutions
Aurorium, a specialty ingredients manufacturer and materials innovation partner, is pleased to announce the launch of Haelium™ Pharmaceutical Solutions.
June 25, 2024
·
2 min read
Press Releases
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
October 29, 2024
·
7 min read
Press Releases
Acella Pharmaceuticals, LLC, an Alora Pharmaceuticals, LLC Subsidiary, Partners with Paloma Health for Hypothyroidism Patients
October 23, 2024
·
2 min read
1 of 26,046
Next